Rare Ebola Strain Reaches Europe as Germany Begins Treatment

A U.S. humanitarian worker infected with the rare Bundibugyo strain of Ebola has been admitted to a Frankfurt hospital, marking a new medical challenge as no approved vaccine currently exists.

Medical status of the patient

A humanitarian worker from the U.S., previously stationed in the Democratic Republic of the Congo (DRC), has been transported to the University Hospital in Frankfurt for specialized care. Medical authorities confirm that the patient is stable and the transport was completed without complications.

The Bundibugyo strain

Testing confirmed the patient is infected with the Bundibugyo strain of the Ebola virus, a rare variant currently fueling an outbreak in the DRC. There is currently no approved vaccine or dedicated medicine specifically for this strain.

Germany’s clinical experience

Germany has established protocols for managing such cases, having previously treated an American doctor for Ebola at the Charite hospital in Berlin earlier this year. That patient was discharged after two weeks of successful treatment. A similar case involving a humanitarian worker occurred in France late last June.

Escalating crisis in the Congo

The outbreak in the DRC has reached critical levels with 702 deaths and 1,926 laboratory-confirmed cases reported. Spanning five provinces, including Ituri and North and South Kivu, this epidemic is spreading faster than any previous Ebola outbreak, prompting the testing of experimental therapies in the Ituri region.